BHS: Bausch Health Companies Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 31,841.84
Book Value ($M) 474.00
Book Value / Share 1.34
Price / Book 17.52
NCAV ($M) -25,572.00
NCAV / Share -72.04
Price / NCAV -0.32

Profitability (mra)
Return on Invested Capital (ROIC) -0.15
Return on Assets (ROA) -0.11
Return on Equity (ROE) -0.71

Liquidity (mrq)
Quick Ratio 0.86
Current Ratio 1.12

Balance Sheet (mrq) ($M)
Current Assets 5,278.00
Assets 31,396.00
Liabilities 30,850.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -203.00
Net Income -1,783.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted -11.81
Earnings Per Share Basic -11.81

Cash Flow Statement (mra) ($M)
Cash From Operations 1,501.00
Cash from Investing -419.00
Cash from Financing -419.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2017-08-09 13D Paulson & Co. Inc. 6.00 -4.47
2017-03-16 13D VA Partners I, LLC 5.20 20.03
2017-03-14 13D/A Pershing Square Capital Management, L.P. 0.00 -100.00
2017-02-07 13G/A Price T Rowe Associates Inc /md/ 0.00 -99.96
2016-06-07 13G/A Ruane, Cunniff & Goldfarb Inc 4.72 -54.45
2015-02-13 13G/A Fmr Llc 3.60

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-08-06 10-Q Quarterly Report – 10-Q
2020-05-07 10-Q Quarterly Report – 10-Q
2020-02-19 10-K Annual Report – 10-K
2019-11-04 10-Q Quarterly Report – 10-Q

(click for more detail)

Similar Companies
ALR – Alere Inc. AMRX – Amneal Pharmaceuticals, Inc.
AZN – AstraZeneca Plc BHVN – Biohaven Pharmaceutical Holding
BMY – Bristol-Myers Squibb Co.


Financial data and stock pages provided by
Fintel.io